EU Medicines Agency Chiefs and their IT Directors Head To Rotterdam
This article was originally published in SRA
Executive Summary
The heads of the national competent authorities (NCAs) for human and veterinary medicines in the EU will gather this week to discuss strategic issues as diverse as drug shortages, innovation and access to new medicines, antimicrobial resistance (AMR) and optimization of regulatory operations.